No commitment: Month-to-month billing
Blood sugar spikes become more controlled: By enhancing insulin response and slowing nutrient absorption, GLP-1 helps prevent sharp post-meal glucose surges
Dosing fundamentals Administration: Once weekly subcutaneous injection Same day each week (consistency matters) Preferably at the same time of day Half-life: Approximately 6 days, supporting weekly dosing Dose escalation: Every 4 weeks, unless: Side effects require holding current dose Individual tolerance suggests faster/slower progression Healthcare provider recommends adjustment Clinical trial doses tested The Phase 2 obesity trial tested multiple dosing arms: Key insight: 8 mg produces nearly the same results as 12 mg with fewer side effectsmaking it a potential "sweet spot" for many users
Injections require a small needle stick once weekly or every two weeks, but they deliver reliable, dose-dependent results backed by years of trial data and real-world outcomes
Essential tracking metrics For each injection: Date, time, dose in mg, syringe units drawn, injection site, concentration of current vial, days since vial reconstitution
